Programme

Saturday May 6th - CEST Time zone

08:00 - 09:00
Room 127-128
IOF Session How IOF can support your efforts in the clinical setting and at the national level Chairpersons : Nicholas Harvey & Leith Zakraoui
  • Opening remarks Leith Zakraoui, Philippe Halbout
  • IOF operations supporting science, research, education, policy/advocacy Philippe Halbout
  • Benefits of collaborating with IOF at the local level: how the CTF programme has been actively supporting secondary fracture prevention efforts in Spain Santiago Palacios
  • Q&A session Leith Zakraoui
  • Closing remarks Leith Zakraoui
08:00 - 09:00
Non-Sponsored Symposia
08:00
Room 119
Implementing Physical activity for older adults at risk in various and specific situations Chairperson : Olivier Bruyère
  • Implementing physical activity as a care for older adults following in geriatric outpatient clinics Mylene Aubertin-Leheudre
  • Implementing physical activity for community-dwelling seniors during isolation periods (e.g. Covid 19 pandemic) Fanny Buckinx
  • Implementing physical activity for older adults in nursing homes Olivier Bruyère
08:00
Room 121
Frailty as a cause and a consequence of hip fractures Chairpersons : Gustavo Duque & Carmen Castillo-Gallego
  • Identification of frailty in hip fracture patients Gustavo Duque
  • Forestalling progression of frailty perioperatively in hip fracture patients: A review of systemic and individualized approaches Lynn McNicoll
  • Frailty in post-hip fracture patients: what should we do? Cristina Alonso-Bouzon
08:00
Room 122
Antiosteoporosis Medications and Fracture Healing. A review of the evidence and some recommendations Chairpersons : Stuart Silverman & Kristina Akesson
  • A brief introduction Stuart Silverman
  • Basics of fracture healing Kristina Akesson
  • Bisphosphonates and fracture healing Manju Chandran
  • Other Antiosteoporosis agents and fracture healing Kassim Javaid
  • Conclusion Nicholas Harvey
  • Question and Answer Session All
08:00
Room 129
How to build the case for effective policy change to address the current and future burden of osteoporosis and fragility fractures Chairperson : Thierry Thomas
  • Opening remarks Thierry Thomas
  • Challenges in current policy and post-fracture care landscape, and the importance of health economics to generate and leverage evidence based data to build the case for policy change Mickaël Hiligsmann
  • The Capture the Fracture® initiative : designing policy tools for effective engagement with policymakers Nicholas Fuggle
  • Panel discussion Manuel Naves Díaz, Maria Luisa Brandi, Sansin Tüzün, Patricia Clark, Famida Jiwa
08:00
Room 133-134
The Brussels study on the early predictors of frailty: results and future perspectives Chairperson : Ivan Bautmans
  • Introduction Concept Butterfly Ivan Bautmans
  • Muscle endurance & self-perceived fatigue predict decline in gait speed and activities of Daily Living after one year follow-up: results from the BUTTERFLY Study Veerle Knoop
  • The effect of medication causing autonomic dysfunction on incidence frailty in octagenarians Aziz Debain
  • Impact of Covid-19 on physical activity, fatigue and frailty in community dwelling older adults: a cross sectional study Veerle Knoop
  • The impact of covid-19 lockdown on the Quality of life, meaningful activities, and frailty in community-dwelling octogenarians: A study in Belgium Stijn De Baets
  • Future perspective: Healthy Ageing Centers Nico de Witte
  • Discussion Ivan Bautmans
08:00
Room 120
Building Communities of Good Practice Globally: The Impact of Bone Health ECHO, Now and Beyond Chairperson : Michael Lewiecki
  • Introduction and global overview Michael Lewiecki
  • Fracture Liaison Service ECHO in the U.S.A. Claire Gill
  • National University of Ireland Galway Bone Health TeleECHO John Carey
  • Bone Health TeleECHO at the American University of Beirut, Lebanon Marlene Chakhtoura
  • Seeking Answers to the challenges in implementing Bone Health TeleECHO in the Asia Pacific Manju Chandran
  • Q & A - Panel discussion All
08:00
Room 130
Skeletal muscle regeneration, fibrosis, and systemic vascular calcifications in Chronic Kidney Disease Chairpersons : Maria Coco & Kwang Chun
  • The Role of calciprotein particles in bone function and vascular calcification Wei Chen
  • Skeletal muscle dysfunction and sarcopenia in chronic kidney disease Thomas J Wilkinson
08:00 - 09:00
Auditorium B
Breakfast Symposium Breakfast Symposium - Bone status assessment with REMS: an update on fracture risk prediction Chairperson : Giuseppe Guglielmi
  • Introduction Giuseppe Guglielmi
  • Fracture risk assessment by REMS in primary and secondary osteoporosis Carmelo Messina
  • REMS for the evaluation of bone Quantity and Quality Giovanni Adami
  • Precision. Repeatability and Diagnostic Accuracy of REMS technology Adolfo Diez-Perez
  • REMS employment in clinical routine: the Polish experience Piotr Leszczynski
  • Take Home Message Giuseppe Guglielmi
08:00 - 09:00
Room 131-132
ESCEO SYMPOSIUM Update on the role of Vitamin D supplementation in the management of musculoskeletal diseases Chairperson : René Rizzoli
  • Epidemiology of Vitamin D deficiency Kevin Cashman
  • Vitamin D and musculoskeletal diseases (effects in depleted and repleted populations) Thierry Chevalley
  • Discussion Stefania Maggi
08:00 - 09:00
Room 118
EUGMS-ESCEO Symposium The 1st World Falls Guidelines: falls and fracture prevention are intertwined Chairpersons : Hubert Blain & Jesper Ryg
  • Risk stratification and Exercise to reduce falls and fracture risk: what are the recommendations of the World Falls Guidelines Tahir Masud
  • Falls prevention at a fracture liaison service: what’s new from the World Falls Guidelines Nathalie van der Velde
  • Interactive discussion Hubert Blain
09:00 - 10:30
Auditorium A
Scientific Session IV Chairpersons : Olivier Bruyère & Claudia Campusano
09:00
Auditorium A
Plenary Lecture 5 Towards a global definition of sarcopenia: Muscle mass, performance and relevant clinical outcomes Roger Fielding
09:30
Auditorium A
Oral communication selected from abstracts OC17: A PHASE 2, 104-WEEK STUDY OF REPEAT LORECIVIVINT INJECTIONS EVALUATING SAFETY, EFFICACY, AND BONE HEALTH UTILIZING QUANTITATIVE COMPUTED TOMOGRAPHY (QCT) IN KNEE OSTEOARTHRITIS (OA-06) Presenting author: J. Tambiah Authors: Y. Yazici, C. Swearingen, H. Ghandehari, J. Britt, I. Simsek, M. Fineman, S. Kennedy and N. Lane
09:40
Auditorium A
Oral communication selected from abstracts OC18: PREDICTION OF KNEE OSTEOARTHRITIS CARTILAGE VOLUME LOSS OVER TIME WITH BASELINE BONE CURVATURE REGIONS AS THE BIOMARKERS. USAGE OF MACHINE LEARNING Presenting author: J. Martel-Pelletier Authors: H. Bonakdari, F. Abram and J.-P. Pelletier
09:50
Auditorium A
Oral communication selected from abstracts OC19: NEW BIOMARKERS IN HAND OSTEOARTHRITIS: THE MICRO-RNAS Presenting author: M. A. Auroux Authors: M. Millet, B. Merle, E. Fontagne, F. Duvet, E. Gineyts, J. C. Rousseau, O. Borel, A. Mercier, E. Lespessailles and R. Chapurlat
10:00
Auditorium A
Oral communication selected from abstracts OC20: BURDEN OF OSTEOARTHRITIS IN CHINA FROM 1990 TO 2019 AND PREDICTIONS OF THE BURDEN IN FUTURE 25 YEARS: FINDINGS FROM THE GLOBAL BURDEN OF DISEASE STUDY 2019 Presenting author: H. Chen Authors: Z. Zhou, X. Fang, D. Hunter, C. Ding and Z. Zhu
10:10
Auditorium A
Oral communication selected from abstracts OC21: FUNCTIONAL PERFORMANCE OUTCOMES AT 1-YEAR FOLLOW-UP AFTER TREATMENT OF KNEE OSTEOARTHRITIS: COMPARISON BETWEEN PLATELET-RICH PLASMA INJECTION AND ORAL PATENTED CRYSTALLINE GLUCOSAMINE SULFATE: PROPENSITY SCORE MATCH PAIR ANALYSIS Presenting author: C. Amarase Authors: S. Ngarmukos, A. Tanavalee, S. C. Tantavisut, C. Tanavalee and N. Jaruthien
10:20
Auditorium A
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award René Rizzoli
10:30 - 12:10
Auditorium A
Scientific Session V Chairpersons : Etienne Cavalier & Maria Luisa Brandi
10:30
Auditorium A
Presentation of the IOF Olof Johnell Science Award Cyrus Cooper & René Rizzoli
10:40
Auditorium A
Plenary Lecture 6 How do we predict and prevent falls in older people? Bess Dawson-Hughes
11:10
Auditorium A
Oral communication selected from abstracts OC22: DIFFERENTIAL EFFECTS ON RISK OF FRACTURE AND DEATH BY SEVERITY OF PRIMARY HYPERPARATHYROIDISM: A DANISH REGISTER STUDY Presenting author: N. C. Harvey Authors: E. Liu, L. Vandenput, M. Lorentzon, E. McCloskey, J. A. Kanis, B. Abrahamsen, L. Rejnmark and H. Johansson
11:20
Auditorium A
Oral communication selected from abstracts OC23: THE IMPORTANCE OF RECENT PREVALENT FRACTURE SITE FOR IMMINENT RISK OF FRACTURE – A RETROSPECTIVE, NATIONWIDE COHORT STUDY OF OLDER SWEDISH MEN AND WOMEN Presenting author: K. Axelsson Authors: H. Litsne and M. Lorentzon
11:30
Auditorium A
Oral communication selected from abstracts OC24: GEOGRAPHICAL VARIATION IN OSTEOPOROSIS CARE: A LONGITUDINAL ANALYSIS OVER 23 YEARS Presenting author: A. R. Jones Authors: P. R. Ebeling, C. Haigh, G. Mishra, H. Teede, J. Enticott and A. J. Vincent
11:40
Auditorium A
Oral communication selected from abstracts OC25: NUMBER OF PRIOR FALLS AND FRACTURE RISK – POTENTIAL ADJUSTMENT OF CONVENTIONAL FRAX PROBABILITIES Presenting author: E. McCloskey Authors: H. Johansson, N. Harvey, M. Lorentzon, S. Morin, W. Leslie and J. A. Kanis
11:50
Auditorium A
Oral communication selected from abstracts OC26: PAIN INCREASES THE RISK FOR SARCOPENIA IN COMMUNITY-DWELLING ADULTS: RESULTS FROM THE ENGLISH LONGITUDINAL STUDY OF AGEING Presenting author: N. Veronese Authors: M. Barbagallo, L. Dominguez, S. Maggi, P. Soysal and L. Smith
12:00
Auditorium A
Oral communication selected from abstracts OC27: POCOSTEO: RAPID, COST-EFFECTIVE AND EASY-TO-USE POINT-OF-CARE (POC) DEVICE FOR EARLY DETECTION AND MONITORING OF OSTEOPOROSIS Presenting author: P. K. Khashayar Authors: J. V. Vanfleteren, P. R. Ragaert, A. V. Vermeulen, R. H. Hoogenboom, F. L. Leys, G. S. Schols, C. O. S. O'Sullivain, M. O. Ortiz, M. J. R. Rubio, P. B. Biggs, D. L. Lenartowicz, K. S. Sasidharan, R. G. Gransee, D. L. Latta, I. E. Etxebarria, N. F. Fahimfar, S. G. H. Gharibzadeh, A. O. Ostovar, F. R. Razi, B. L. Larijani, I. N. Nabipour, B. L. Luegger, B. O. P. Obermayer-Pietsch and H. P. Dimai
12:15 - 13:45
Auditorium A
Sponsored Lunch Satellite Symposium

* See details on the Sponsored Satellite Symposia page

12:15 - 13:45
Auditorium B
Sponsored Lunch Satellite Symposium

* See details on the Sponsored Satellite Symposia page

14:00 - 15:00
Meet-The-Expert Session
14:00
Room 121
Management of hypoparathyroidism Maria Luisa Brandi
14:00
Room 133-134
Osteoporosis treatments and material level properties of bone Xavier Nogues
14:00
Room 120
Changing the bone paradigm in kidney transplant recipients Jorge Cannata-Andia
14:00
Room 119
Treatments of endometriosis and bone health Santiago Palacios
14:00 - 15:00
Poster Area
Poster Viewing Session II
14:00 - 15:10
Podium
Oral presentation of selected posters Chairperson : Elaine Dennison
14:00
Podium
P687 ASSOCIATIONS BETWEEN GUT MICROBIOTA AND SARCOPENIA OR ITS DEFINING PARAMETERS: A SYSTEMATIC REVIEW Presenting author: L. Lapauw Authors: A. Rutten, J. Dupont, L. Dedeyn, N. Amini, L. Vercauteren, J. Raes and E. Gielen
14:07
Podium
P709 PRELIMINARY RESULTS OF THE INVOLVEMENT OF THE ENDOCANNABINOID SYSTEM IN FIBROUS BONE DYSPLASIA Presenting author: I. Falsetti Authors: G. Palmini, C. Aurilia, S. Donati, F. Marini, G. Galli, R. Zonefrati, T. Iantomasi and M. L. Brandi
14:14
Podium
P1030 A NEW TOOL FOR INCIDENT FRACTURE RISK IDENTIFICATION IN MEN: THE REMS-BASED FRAGILITY SCORE (FS) Presenting author: P. Pisani Authors: F. Conversano, M. Muratore, G. Adami, M. L. Brandi, C. Caffarelli, E. Casciaro, M. Di Paola, R. Franchini, D. Gatti, S. Gonnelli, G. Guglielmi, F. A. Lombardi, A. Natale, V. Testini and S. Casciaro
14:21
Podium
P1033 EFFECT OF VITAMIN D3, OMEGA-3S AND A SIMPLE HOME EXERCISE PROGRAM ON BMD IN EUROPEAN OLDER ADULTS: THE DO-HEALTH RANDOMIZED CONTROLLED TRIAL Presenting author: M. Kistler-Fischbacher Authors: G. Armbrecht, S. Gängler, W. Lang, J. A. Kanis, B. Dawson-Hughes, R. Rizzoli, G. A. Wanner and H. A. Bischoff-Ferrari
14:28
Podium
P340 A PLACEBO-CONTROLLED, SINGLE BLIND EXTENSION STUDY (OA-07) EVALUATING THE SAFETY AND EFFICACY OF LORECIVIVINT IN SUBJECTS WITH SEVERE OSTEOARTHRITIS OF THE KNEE: RADIOGRAPHIC AND PAIN OUTCOMES AT 24 AND 30 MONTHS Presenting author: J. Tambiah Authors: Y. Yazici, C. Swearingen, V. Lopez, J. Britt, S. Kennedy and T. McAlindon
14:35
Podium
P253 DYNAPENIA, LOW MUSCLE MASS OR SARCOPENIA: WHICH BEST PREDICTS MOBILITY DECLINE IN OLDER WOMEN WITH NORMAL GAIT SPEED? Presenting author: T. S. Alexandre Authors: I. Souza, D. C. Oliveira, T. B. Souza, P. C. Ramírez, N. C. Soares, M. M. Luiz, M. L. B. Delinocente, A. Steptoe and C. Oliveira
14:42
Podium
P381 SARCOPENIA PREVALENCE, INCIDENCE, AND ASSOCIATION WITH 6 YEARS INCIDENT FRAGILITY FRACTURES IN SWISS POSTMENOPAUSAL WOMEN Presenting author: C. Vendrami Authors: E. Shevroja, E. Gonzalez Rodriguez, G. Waeber, P. Vollenweider, P. Marques-Vidal, D. Hans and O. Lamy
14:49
Podium
P460 ASSOCIATION BETWEEN POLLUTION AND FRAILTY IN OLDER PEOPLE: A CROSS-SECTIONAL ANALYSIS OF THE UK BIOBANK Presenting author: N. Veronese Authors: L. Maniscalco, D. Matranga, G. Lacca, L. Dominguez and M. Barbagallo
14:56
Podium
P453 DEVELOPMENT OF TWO INNOVANT PERFORMANCE-BASED OBJECTIVE MEASURES IN FELINE OSTEOARTHRITIS: THEIR RELIABILITY AND RESPONSIVENESS TO ANALGESIC TREATMENT Presenting author: J.-P. Pelletier Authors: A. Delsart, M. Moreau, C. Otis, M. Frezier, B. Lussier, J. Martel-Pelletier and E. Troncy
15:03
Podium
P498 DEVELOPMENT AND VALIDATION OF NEW EXERCISES TO PROMOTE PHYSICAL ACTIVITY IN NURSING HOME SETTINGS, THROUGH QUALITATIVE METHOD Presenting author: F. Buckinx Authors: L. Maton, V. Dalimier, A. Mouton, L. Lengelé, J.-Y. Reginster and O. Bruyère
14:00 - 15:00
Room 131-132
Special Educational Lecture Osteoporosis - personalized management Adolfo Diez-Perez
14:00 - 15:00
Room 122
Evidence-based and patient-centered recommendations for the treatment of osteoporosis in men: Outcomes of an ESCEO Working Group organized under the auspices of the World Health Organization Collaborating Center for Epidemiology of Musculoskeletal Health Chairpersons : Jean-Marc Kaufman & René Rizzoli
  • Screening, diagnosis and identification of patients to be treated John A. Kanis
  • Outcomes of a new meta-analysis assessing pharmacological treatments in osteoporosis in men Charlotte Beaudart
  • Recommendations from ESCEO: GRADE assessment Nick Fuggle
14:00 - 15:00
Room 118
ESCEO and IOF guidance for the conduct and reporting of Real-World Evidence studies in osteoporosis Chairpersons : Nicholas Harvey & Andrea Laslop
  • Real World Evidence: a critical new approach for pharmaceutical regulation Andrea Laslop
  • State-of-the-art epidemiology for Real World Evidence Daniel Prieto-Alhambra
  • Real World Evidence: the future of research in osteoporosis? Peyman Hadji
  • Q/A-Panel discussion: René Rizzoli (leader), Andrea Laslop, Daniel Prieto Alhambra, Peyman Hadji, Nicholas Harvey
14:00 - 15:00
Room 130
Sponsored Meet-The-Expert Session

* See details on the Sponsored Satellite Symposia page

15:00 - 17:00
Auditorium A
Scientific Session VI Chairpersons : Nicola Veronese & Manju Chandran
15:00
Auditorium A
Plenary Lecture 7 Pharmacoepidemiology and big data in the post-COVID era Daniel Prieto-Alhambra
15:30
Auditorium A
Oral communication selected from abstracts OC28: MUSCULOSKELETAL FUNCTIONAL ABILITY AND STRENGTH IN SUB-SAHARAN AFRICA (THE MUFASSA STUDY): DETERMINING SARCOPENIA PREVALENCE IN SOUTH AFRICA, THE GAMBIA AND ZIMBABWE Presenting author: K. A. Ward Authors: L. Micklesfield, T. Manyanga, M. K. Jallow, B. Cassim, L. Gates, C. Pearse, C. Cooper, A. J. Burton, H. Wilson, R. Ferrand, M. Jobe and C. L. Gregson
15:40
Auditorium A
Oral communication selected from abstracts OC29: TREATMENT PERSISTENCE OF JANUS-KINASE (JAK) INHIBITORS IN RHEUMATOID ARTHRITIS AND THE EFFECT ON GLUCOCORTICOIDS USAGE AND THE IMPACT OF COMEDICATION OF CONVENTIONAL DMARDS ON TREATMENT PERSISTENCE: RETROSPECTIVE STUDY IN THE AUSTRALIAN POPULATION Presenting author: L. Scheepers Authors: Y. Yang, Y. Chen and G. Jones
15:50
Auditorium A
Oral communication selected from abstracts OC30: INTEGRATING POST-FRACTURE CARE INTO THE PRIMARY CARE SETTING (INTERFRACT): A MIXED-METHODS STUDY TO CO-DESIGN A CARE PROGRAM TO IMPROVE RATES OF OSTEOPOROSIS AND FRACTURE TREATMENT Presenting author: J. Talevski Authors: A. Beauchamp, S. Bird and R. Daly
16:00
Auditorium A
Oral communication selected from abstracts OC31: A DEEP LEARNING, COMPUTER VISION APPROACH TO SEGMENTATION OF BONE MICROARCHITECTURE HIGHLIGHTS THE ROLE OF THE TRABECULAR COMPARTMENT IN FRACTURE DISCRIMINATION Presenting author: N. Fuggle Authors: S. Lu, M. Ó Breasail, L. Westbury, K. Ward, E. Dennison, S. Mahmoodi and C. Cooper
16:10
Auditorium A
Oral communication selected from abstracts OC32: EVALUATING THE DIAGNOSTIC VALUE OF AN AUTOMATIC IMAGE ANALYSES SYSTEM FOR OSTEOPOROSIS AND SARCOPENIA IN OLDER MEN: MROS STUDY Presenting author: M. Imani Authors: T. Ngoc Quoc Dao, E. Meijering, S. Vogrin, E. S. Orwoll, P. Cawthon and G. Duque
16:20
Auditorium A
Oral communication selected from abstracts OC33: DISORGANIZED BONE COMPONENTS: A NOVEL BIOMARKER UNRELATED TO BONE DENSITY AND STRUCTURE THAT MAY HOLD THE KEY TO THE DIAGNOSIS OF ATYPICAL OR STRESS FRACTURES Presenting author: R. Zebaze Authors: C. S.-L. Shore-Lorenti, C. Chiang, N. Nguyen, D. Djopseu, T. Makebeh, Z. Zhang, M. Milat and P. R. Ebeling
16:30
Auditorium A
Plenary Lecture 8 Hopes and disappointments of new and emerging OA therapies Francis Berenbaum
15:00 - 16:45
Room 131-132
Committee of Scientific Advisors Special Session Osteoporosis state-of-the-art from the IOF Committee of Scientific Advisors Chairpersons : Nicholas Harvey & Serge Ferrari
  • Advances in HRpQCT – from novel phenotypes to improved fracture risk prediction Mattias Lorentzon
  • Antiresorptives and dental implant healing-a global consensus statement Aliya Khan
  • Musculoskeletal ageing-a global perspective Kate Ward